SEARCH

SEARCH BY CITATION

References

  • Buggins, A.G., Pepper, C., Patten, P.E., Hewamana, S., Gohil, S., Moorhead, J., Folarin, N., Yallop, D., Thomas, N.S., Mufti, G.J., Fegan, C. & Devereux, S. (2010) Interaction with vascular endothelium enhances survival in primary chronic lymphocytic leukemia cells via NF-kappaB activation and de novo gene transcription. Cancer Research, 70, 75237533.
  • Buggins, A.G., Levi, A., Gohil, S., Fishlock, K., Patten, P.E., Calle, Y., Yallop, D. & Devereux, S. (2011) Evidence for a macromolecular complex in poor prognosis CLL that contains CD38, CD49d, CD44 and MMP-9. British Journal of Haematology, 154, 216222.
  • Coscia, M., Pantaleoni, F., Riganti, C., Vitale, C., Rigoni, M., Peola, S., Castella, B., Foglietta, M., Griggio, V., Drandi, D., Ladetto, M., Bosia, A., Boccadoro, M. & Massaia, M. (2011) IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells. Leukemia, 25, 828837.
  • Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J., Lichtman, S.M., Schulman, P., Vinciguerra, V.P., Rai, K.R., Ferrarini, M. & Chiorazzi, N. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood, 94, 18401847.
  • Damle, R.N., Temburni, S., Calissano, C., Yancopoulos, S., Banapour, T., Sison, C., Allen, S.L., Rai, K.R. & Chiorazzi, N. (2007) CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells. Blood, 110, 33523359.
  • Deaglio, S., Vaisitti, T., Bergui, L., Bonello, L., Horenstein, A.L., Tamagnone, L., Boumsell, L. & Malavasi, F. (2005) CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival. Blood, 105, 30423050.
  • Ferretti, E., Bertolotto, M., Deaglio, S., Tripodo, C., Ribatti, D., Audrito, V., Blengio, F., Matis, S., Zupo, S., Rossi, D., Ottonello, L., Gaidano, G., Malavasi, F., Pistoia, V. & Corcione, A. (2011) A novel role of the CX(3)CR1/CX(3)CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment. Leukemia, 25, 12681277.
  • Herishanu, Y., Perez-Galan, P., Liu, D., Biancotto, A., Pittaluga, S., Vire, B., Gibellini, F., Njuguna, N., Lee, E., Stennett, L., Raghavachari, N., Liu, P., McCoy, J.P., Raffeld, M., Stetler-Stevenson, M., Yuan, C., Sherry, R., Arthur, D.C., Maric, I., White, T., Marti, G.E., Munson, P., Wilson, W.H. & Wiestner, A. (2011) The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood, 117, 563574.
  • Majid, A., Lin, T.T., Best, G., Fishlock, K., Hewamana, S., Pratt, G., Yallop, D., Buggins, A.G., Wagner, S., Kennedy, B.J., Miall, F., Hills, R., Devereux, S., Oscier, D.G., Dyer, M.J., Fegan, C. & Pepper, C. (2011) CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL. Leukemia Research, 35, 750756.
  • Messmer, B.T., Messmer, D., Allen, S.L., Kolitz, J.E., Kudalkar, P., Cesar, D., Murphy, E.J., Koduru, P., Ferrarini, M., Zupo, S., Cutrona, G., Damle, R.N., Wasil, T., Rai, K.R., Hellerstein, M.K. & Chiorazzi, N. (2005) In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. Journal of Clinical Investigation, 115, 755764.
  • Patten, P., Devereux, S., Buggins, A., Bonyhadi, M., Frohlich, M. & Berenson, R.J. (2005) Effect of CD3/CD28 bead-activated and expanded T cells on leukemic B cells in chronic lymphocytic leukemia. Journal of Immunology, 174, 65626563 author reply 6563.
  • Patten, P.E., Buggins, A.G., Richards, J., Wotherspoon, A., Salisbury, J., Mufti, G.J., Hamblin, T.J. & Devereux, S. (2008) CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment. Blood, 111, 51735181.
  • Pepper, C., Mahdi, J.G., Buggins, A.G., Hewamana, S., Walsby, E., Mahdi, E., Al-Haza'a, A., Mahdi, A.J., Lin, T.T., Pearce, L., Morgan, L., Bowen, I.D., Brennan, P. & Fegan, C. (2011) Two novel aspirin analogues show selective cytotoxicity in primary chronic lymphocytic leukaemia cells that is associated with dual inhibition of Rel A and COX-2. Cell Proliferation, 44, 380390.
  • Plander, M., Seegers, S., Ugocsai, P., Diermeier-Daucher, S., Ivanyi, J., Schmitz, G., Hofstadter, F., Schwarz, S., Orso, E., Knuchel, R. & Brockhoff, G. (2009) Different proliferative and survival capacity of CLL-cells in a newly established in vitro model for pseudofollicles. Leukemia, 23, 21182128.
  • Rassenti, L.Z., Huynh, L., Toy, T.L., Chen, L., Keating, M.J., Gribben, J.G., Neuberg, D.S., Flinn, I.W., Rai, K.R., Byrd, J.C., Kay, N.E., Greaves, A., Weiss, A. & Kipps, T.J. (2004) ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. New England Journal of Medicine, 351, 893901.
  • Schmid, C. & Isaacson, P.G. (1994) Proliferation centres in B-cell malignant lymphoma, lymphocytic (B-CLL): an immunophenotypic study. Histopathology, 24, 445451.
  • Scielzo, C., Apollonio, B., Scarfo, L., Janus, A., Muzio, M., Ten Hacken, E., Ghia, P. & Caligaris-Cappio, F. (2011) The functional in vitro response to CD40 ligation reflects a different clinical outcome in patients with chronic lymphocytic leukemia. Leukemia, 25, 17601767.
  • Shanafelt, T.D., Geyer, S.M., Bone, N.D., Tschumper, R.C., Witzig, T.E., Nowakowski, G.S., Zent, C.S., Call, T.G., Laplant, B., Dewald, G.W., Jelinek, D.F. & Kay, N.E. (2008) CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential. British Journal of Haematology, 140, 537546.
  • Zucchetto, A., Benedetti, D., Tripodo, C., Bomben, R., Dal Bo, M., Marconi, D., Bossi, F., Lorenzon, D., Degan, M., Rossi, F.M., Rossi, D., Bulian, P., Franco, V., Del Poeta, G., Deaglio, S., Gaidano, G., Tedesco, F., Malavasi, F. & Gattei, V. (2009) CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival. Cancer Research, 69, 40014009.